Gene expression profiling of 14 genes in CTCs isolated in vivo from 108 high-risk PCa patients revealed high heterogeneity, while direct comparison with CTC-enumeration (CellSearch®), PSA-EPISPOT, and immunofluorescence showed a relatively low concordance between these different methodologies [75]. The gene discussed is KLK3; the disease is posterior cortical atrophy.